Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The αO2-PRBC.Thal Study on the Use of Hemanext One® RBC Storage System for Blood Transfusion Support on Transfusion-dependent Thalassemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07055503
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:48.213328+00:00
Published At
2025-12-17T00:00:00+00:00
Record Updated At
2025-12-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Transfusion-dependent Beta-Thalassemia", "Blood Transfusion"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-17"
protocolSection.identificationModule.nctId
"NCT07055503"
protocolSection.identificationModule.officialTitle
"The \u03b1O2-PRBC.Thal Study on the Use of Hemanext One\u00ae RBC Storage System for Blood Transfusion Support on Transfusion-dependent Thalassemia"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Transfusion-dependent Beta-Thalassemia (protocolSection.conditionsModule.conditions)
  • Blood Transfusion (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.